User Fees for DTC Ad Review All Over Again

In another attempt to allow the drug industry to pay the FDA to review broadcast TV DTC ads, the Bush administration is attempting to resurrect user fees.

"The proposed 2009 budget [Bush] sent to Congress this month calls for $14 million from fees to fund 27 FDA positions devoted to the consumer-ad-review program. In exchange, the FDA would review TV drug ads within 45 days of getting them from drugmakers — which is faster than many reviews occur now — and before the ads are seen by millions of viewers." (See USA Today article here.)

In case you are trying to keep up with the on again/off again DTC user fee issue, check out these previous Pharma Marketing Blog posts (in reverse chronological order):

• FDA Won't be Previewing TV DTC Ads!
• FDA DTC Payola Out, You Pay In!
• PDUFA Payola!
• Pay Per DTC Ad View Update
• Pay-(FDA)-Per-(Pre)View of DTC